Recognizing emphysematous gastritis

Amanda Weaver; Russell Weintraub; Brian Smith

doi:10.1097/01.JAA.0000550284.27345.5e

Recognizing emphysematous gastritis

JAAPA. 2019 Feb;32(2):27-29. doi: 10.1097/01.JAA.0000550284.27345.5e.

Authors

Amanda Weaver¹, Russell Weintraub, Brian Smith

Affiliation

¹ Amanda Weaver was a student in the PA program at Nova Southeastern University in Ft. Myers, Fla., when this article was written. She now practices orthopedic surgery at ProHealth Select in Boca Raton, Fla. At Physicians Regional Medical Center in Naples, Fla., Russell Weintraub practices in the Department of Medicine and Brian Smith practices in the Department of Surgery. The authors have disclosed no potential conflicts of interest, financial or otherwise.

PMID: 30694948
DOI: 10.1097/01.JAA.0000550284.27345.5e

Abstract

Emphysematous gastritis is a rare disease caused by gas-forming organisms. This article describes how a CT scan and aggressive IV drug therapy helped clinicians beat the odds for a patient with this high-mortality disease.

Publication types

Case Reports

MeSH terms

Administration, Intravenous
Aged
Emphysema / diagnostic imaging*
Emphysema / drug therapy*
Gastritis / diagnostic imaging*
Gastritis / drug therapy*
Humans
Levofloxacin / administration & dosage
Male
Metronidazole / administration & dosage
Tomography, X-Ray Computed / methods*

Substances

Metronidazole
Levofloxacin